Latest / Teal Talk–An Ovarian Cancer Podcast
FDA Approval for Low-Grade Serous Ovarian Cancer: A New Era in Treatment
Discover a groundbreaking advancement in ovarian cancer care in this episode of Teal Talk – An Ovarian Cancer Podcast! Leading experts Dr. Deborah Richardson and Dr. Rachel Grisham join the discussion to explore the FDA approval of the first targeted treatment for recurrent low-grade serous ovarian cancer (LGSOC) with KRAS mutations. Whether you're a patient, caregiver, or healthcare provider, this episode offers vital insights into the future of ovarian cancer treatment.
💬 Like, comment, and subscribe for more vital discussions about ovarian cancer.
📋 Survey Link…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.